A systematic review of BNP and NT-proBNP in the management of heart failure: Overview and methods

Heart Failure Reviews

Volumn 19, Issue 4, 2014, Pages 413-419

  Oremus, Mark ^a   McKelvie, Robert ^a   Don Wauchope, Andrew ^a   Santaguida, Pasqualina L ^a   Ali, Usman ^a   Balion, Cynthia ^a   Hill, Stephen ^a   Booth, Ronald ^b   Brown, Judy A ^a   Bustamam, Amy ^a   Sohel, Nazmul ^a   Raina, Parminder ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

BNP; Chronic; Heart failure; NT proBNP; Stable; Systematic review

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76); PROTEIN PRECURSOR;

CARDIOVASCULAR MORTALITY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; HEART FAILURE; HUMAN; INTERMETHOD COMPARISON; META ANALYSIS; PATIENT CARE; PATIENT IDENTIFICATION; PROGNOSIS; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW; BLOOD; DISEASE MANAGEMENT;

DISEASE MANAGEMENT; HEART FAILURE; HUMANS; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROGNOSIS; PROTEIN PRECURSORS;

EID: 84906331316     PISSN: 13824147     EISSN: 15737322     Source Type: Journal    
DOI: 10.1007/s10741-014-9440-0     Document Type: Review

References (33)

1. Metra M, Ponikowski P, Dickstein K, McMurray JJV, Gavazzi A, Bergh C-H et al (2007) Advanced chronic heart failure: a position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 9:684-694. doi:10.1016/j.ejheart.2007. 04.003 (Pubitemid 46705572)
2. Heart Failure Society of America, Lindenfeld J, Albert NM, Boehmer JP, Collins SP, Ezekowitz JA et al (2010) HFSA 2010 comprehensive heart failure practice guideline. J Card Fail 16:e1-e194. doi:10.1016/j.cardfail.2010.04.004
3. Felker GM, Adams KF Jr, Konstam MA, O'Connor CM, Gheorghiade M (2003) The problem of decompensated heart failure: nomenclature, classification, and risk stratification. Am Heart J 145:S18-S25. doi:10.1067/mhj.2003.150 (Pubitemid 36207921)
4. Arnold LM, Crouch MA, Carroll NV, Oinonen MJ (2006) Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure. Pharmacotherapy 26:1078-1085. doi:10.1592/phco.26.8.1078 (Pubitemid 44167816)
5. McKelvie RS, Moe GW, Ezekowitz JA, Heckman GA, Costigan J, Ducharme A et al (2013) The 2012 Canadian Cardiovascular Society heart failure management guidelines update: focus on acute and chronic heart failure. Can J Cardiol 29:168-181. doi:10.1016/j.cjca.2012.10.007
6. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM et al (2011) Heart disease and stroke statistics - 2011 update: a report from the American Heart Association. Circ Cardiovasc Qual Outcomes 123:e18-e209. doi:10.1161/CIR.0b013e3182009701
7. Addicks K, Forssmann WG, Henkel H, Holthausen U, Menz V, Rippegather G, Ziskoven D (1989) Calcium-calmodulinantagonists influence release of cardiodilatin/ANP from atrial cardiocytes. In: Kaufmann W, Wambach G (eds) Endocrinology of the heart. Springer, Berlin, pp 233-234
8. McMurray JJV, Adamopoulos C, Anker S, Auricchio A (2012) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 33:1787-1847
9. Di Angelantonio E, Chowdhury R, Sarwar N, Ray KK, Gobin R, Saleheen D et al (2009) B-type natriuretic peptides and cardiovascular risk: systematic review and meta-analysis of 40 prospective studies. Circ Cardiovasc Qual Outcomes 120:2177-2187. doi:10.1161/CIRCULATIONAHA.109.884866
10. Doust JA, Pietrzak E, Dobson A, Glasziou P (2005) How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review. BMJ 330:625. doi:10.1136/bmj.330.7492.62
11. Vesbianu D, Vesbianu C, Bernstein P, Kouides R (2008) Plasma brain natriuretic peptide - an independent predictor of mortality and rehospitalization in congestive heart failure - a meta-analysis. World Heart J 1:349-354
12. Oremus M, Raina PS, Santaguida P, Balion CM, McQueen MJ, McKelvie R et al (2008) A systematic review of BNP as a predictor of prognosis in persons with coronary artery disease. Clin Biochem 41:260-265. doi:10.1016/j.clinbiochem. 2007.09.011 (Pubitemid 351240898)
13. Balion C, Don-Wauchope A, Hill S, Santaguida PL, Booth R, Brown JA, Oremus M, Ali U, Bustamam A, Sohel N, McKelvie R, Raina P (2013) Use of natriuretic peptide measurement in the management of heart failure. Comparative Effectiveness Reviews, No. 126. AHRQ Publication No. 13(14)-EHC118-EF. www.effectivehealthcare.ahrq.gov/reports/final.cfm
14. Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB et al (2011) QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155:529-536. doi:10.1059/0003-4819-155-8- 201110180-00009
15. Hayden JA, Côté P, Bombardier C (2006) Evaluation of the quality of prognosis studies in systematic reviews. Ann Intern Med 144:427-437. doi:10.7326/0003-4819-144-6-200603210-00010 (Pubitemid 46768164)
16. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ et al (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17:1-12. doi:10.1016/0197-2456(95)00134- 4 (Pubitemid 26120810)
17. Chu H, Cole SR (2006) Bivariate meta-analysis of sensitivity and specificity with sparse data: a generalized linear mixed model approach. J Clin Epidemiol 59:1331-1332. doi:10.1016/j.jclinepi.2006.06.011 (Pubitemid 44708615)
18. Reitsma JB, Glas AS, Rutjes AW, Scholten RJ, Bossuyt PM, Zwinderman AH (2005) Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol 58:982-990. doi:10.1016/j.jclinepi.2005.02.022 (Pubitemid 41316441)
19. Van Houwelingen HC, Arends LR, Stijnen T (2002) Advanced methods in meta-analysis: multivariate approach and meta-regression. Stat Med 21:589-624. doi:10.1002/sim.1040 (Pubitemid 34141379)
20. Van Houwelingen HC, Zwinderman KH, Stijnen T (1993) A bivariate approach to meta-analysis. Stat Med 12:2273-2284. doi:10.1002/sim.4780122405 (Pubitemid 24007148)
21. Higgins JPT, Green S (eds) (2011) Cochrane handbook for systematic reviews of interventions, version 5.1.0 [updated March 2011]. The Cochrane Collaboration. Available from www.cochrane-handbook.org
22. Deeks JJ, Macaskill P, Irwig L (2005) The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol 58:882-893. doi:10.1016/j.jclinepi.2005.01.016 (Pubitemid 41115772)
23. Zamora J, Abraira V, Muriel A, Khan K, Coomarasamy A (2006) Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol 6:31. doi:10.1186/1471-2288-6-31
24. Agency for Healthcare Research and Quality (2014) Methods guide for effectiveness and comparative effectiveness reviews. AHRQ Publication No. 10(14)-EHC063-EF. Agency for Healthcare Research and Quality, Rockville, MD. http://www.effectivehealthcare.ahrq.gov/search-for-guides-reviews-and-reports/? pageaction=displayproduct&mp=1&productID=318
25. Agency for Healthcare Research and Quality (2012) Methods guide for medical test reviews. AHRQ Publication No. 12-EC017. Agency for Healthcare Research and Quality, Rockville, MD. http://effectivehealthcare.ahrq.gov/index. cfm/search-for-guides-reviews-and-reports/?pageaction=displayproduct& productid=558
26. Singh S, Chang SM, Matchar DB, Bass EB (2012) Chapter 7: grading a body of evidence on diagnostic tests. J Gen Intern Med 27(1 Suppl):47-55. doi:10.1007/s11606-012-2021-9
27. Moher D, Liberati A, Tetzlaff J, Altman DG, PRIMSA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151(264-9):W64. doi:10.7326/0003-4819-151-4-200908180-00135
28. van Kimmenade RR, Januzzi JL Jr, Ellinor PT, Sharma UC, Bakker JA, Low AF et al (2006) Utility of amino-terminal probrain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure. J Am Coll Cardiol 48:1217-1224. doi:10.1016/j.jacc.2006.03.061 (Pubitemid 44345127)
29. Januzzi JL, van Kimmenade R, Lainchbury J, Bayes-Genis A, Ordóñnez-Llanos J, Santalo-Bel M et al (2006) NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study. Eur Heart J 27:330-337. doi:10.1093/eurheartj/ehi631 (Pubitemid 43100029)
30. Maisel A, Mueller C, Nowak R, Peacock WF, Landsberg JW, Ponikowski P et al (2010) Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. J Am Coll Cardiol 55:2062-2076. doi:10.1016/j.jacc.2010.02.025
31. Berger R, Moertl D, Peter S, Ahmadi R, Huelsmann M, Yamuti S et al (2010) N-terminal pro-B-type natriuretic peptide-guided, intensive patient management in addition to multidisciplinary care in chronic heart failure a 3-arm, prospective, randomized pilot study. J Am Coll Cardiol 55:645-653. doi:10.1016/j.jacc.2009.08.078
32. Persson H, Erntell H, Eriksson B, Johansson G, Swedberg K, Dahlström U (2010) Improved pharmacological therapy of chronic heart failure in primary care: a randomized study of NT-proBNP guided management of heart failure - SIGNAL-HF (Swedish intervention study - guidelines and NT-proBNP analysis in heart failure). Eur J Heart Fail 12:1300-1308. doi:10.1093/eurjhf/hfq169
33. Greenland P, Alpert JS, Beller GA, Benjamin EJ, Budoff MJ, Fayad ZA et al (2010) 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults. J Am Coll Cardiol 56:e50-e103. doi:10.1016/j.jacc.2010.09. 001